Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients
Frontiers in Nutrition · 28.07.2025 · 12
DOI: 10.3389/fnut.2025.1591508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 28.07.2025. Verfasst von Yu Peng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Department of Hematology-Oncology, Chongqing University Cancer Hosp…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma and often carries a poor prognosis. Current prognostic systems such as the International Prognostic Index (IPI) and National Comprehensive Cancer Network (NCCN)-IPI do not incorporate patients’ nutritional, immune, or inflammatory status, which may affect outcomes.
Methods
We retrospectively analyzed 423 newly diagnosed DLBCL patients and collected 12 clinical indicators reflecting nutritional, immune, and inflammatory status. Patients were randomly divided into training and validation sets in a 7:3 ratio. A LASSO-Cox regression model was applied to identify variables for constructing the Nutritional and Immune-Inflammatory Scoring System (NII). The independent prognostic value of NII was evaluated using univariable and multivariable Cox regression analyses. Its added prognostic value was further assessed in combination with the IPI and NCCN-IPI.
Results
We developed the NII, including Nutritional Risk Screening 2002 (NRS2002), Geriatric Nutritional Risk Index (GNRI), systemic immune-inflammation index (SII), lactic dehydrogenase to albumin ratio (LAR), β 2-microglobulin ( β 2-MG), and CD8 + T cells. A high NII (≥ 6) effectively identifies high-risk DLBCL patients and serves as an independent prognostic factor beyond other clinical characteristic, IPI, and NCCN-IPI. DLBCL patients with a high NII (≥ 6) exhibit significantly adverse clinical features, including older age, lower frequency of the non-GCB subtype, advanced Ann Arbor stage (III/IV), poor performance status (ECOG PS ≥ 2), involvement of ≥ 2 extranodal sites, presence of B symptoms, elevated lactate dehydrogenase (LDH) levels, and classification into higher-risk groups according to IPI and NCCN-IPI. Combining NII with IPI or NCCN-IPI significantly improves the assessment of patient prognosis compared to using IPI or NCCN-IPI alone.
Conclusion
The NII score, integrating readily available nutritional, immune, and inflammatory markers, enhances prognostic accuracy in DLBCL and complements conventional scoring systems. This simple tool may aid in early identification of high-risk patients and guide personalized treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China.
- School of Medicine, Chongqing University, Chongqing, China.
Zitieren
APA
Peng, Y., Jiang, T., Chen, S., Tang, X., Zhang, Y., Li, L., Li, L., Ran, L., Wu, X., Li, J., Zhang, W., Li, N., Yang, Z., & Liu, Y. (2025). Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1591508
Vancouver
Peng Y, Jiang T, Chen S, Tang X, Zhang Y, Li L, et al. Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1591508
BibTeX
@article{Peng2025,
author = {Peng, Yu and Jiang, Tingting and Chen, Shuang and Tang, Xinyi and Zhang, Yakun and Li, Liangmei and Li, Lian and Ran, Longrong and Wu, Xuelian and Li, Jun and Zhang, Wei and Li, Nanjun and Yang, Zailin and Liu, Yao},
title = {Nutritional and immune-inflammatory scoring system for predicting outcomes in newly diagnosed diffuse large B-cell lymphoma patients},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1591508}
}
EUVIMED